These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8930184)

  • 1. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats.
    Mazzola-Pomietto P; Aulakh CS; Huang SJ; Murphy DL
    J Pharmacol Exp Ther; 1996 Nov; 279(2):782-9. PubMed ID: 8930184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively.
    Aulakh CS; Mazzola-Pomietto P; Hulihan-Giblin BA; Murphy DL
    Neuropsychopharmacology; 1995 Aug; 13(1):1-8. PubMed ID: 8526967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses.
    Bagdy G; Makara GB
    Endocrinology; 1994 Mar; 134(3):1127-31. PubMed ID: 8119151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses.
    Bagdy G
    Behav Brain Res; 1996; 73(1-2):277-80. PubMed ID: 8788518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated cocaine modifies the neuroendocrine responses to the 5-HT1C/5-HT2 receptor agonist DOI.
    Levy AD; Li Q; Alvarez Sanz MC; Rittenhouse PA; Brownfield MS; Van de Kar LD
    Eur J Pharmacol; 1992 Oct; 221(1):121-7. PubMed ID: 1333968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
    Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
    Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoteoline, a putative serotonin antagonist, inhibits meta -chlorophenylpiperazine, but not 1-(2, -dimethoxy-4-iodphenyl)-2-aminopropane and 8-hydroxy-2-(di-n-propylamino)-tetraline-induced increase of serum prolactin levels.
    Zhelyazkova-Savova MD; Negrev N
    Pharmacol Res; 2000 Jul; 42(1):93-9. PubMed ID: 10860641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
    Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
    Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD
    J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
    Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
    Pechnick RN; George R; Poland RE; Hiramatsu M; Cho AK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):534-40. PubMed ID: 2547936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a low tryptophan diet on the prolactin responses to the 5-HT2A agonist DOI in the rat.
    Franklin M; Cowen PJ
    Pharmacopsychiatry; 2001 Jul; 34(4):147-9. PubMed ID: 11518476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    Neuroendocrinology; 1993 May; 57(5):869-74. PubMed ID: 8413823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonists block development of tolerance to m-CPP-induced increases in ACTH concentrations in rats.
    Mazzola-Pomietto P; Aulakh CS; Murphy DL
    Eur J Pharmacol; 1996 Jul; 308(3):329-33. PubMed ID: 8858308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
    Bagdy G; Calogero AE; Murphy DL; Szemeredi K
    Endocrinology; 1989 Nov; 125(5):2664-9. PubMed ID: 2551661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.